Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 256462, 8 pages
http://dx.doi.org/10.1155/2013/256462
Research Article

Decreased PERP Expression on Peripheral Blood Mononuclear Cells from Patient with Rheumatoid Arthritis Negatively Correlates with Disease Activity

1The First Hospital of Xiamen University, Xiamen 361003, China
2Division of Rheumatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
3British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK
4Department of Immunology, Chengdu Medical College, Chengdu 610000, China
5Department of Rheumatology and Clinical Immunology, The First Hospital of Xiamen University, Xiamen 361003, China

Received 4 May 2013; Accepted 20 July 2013

Academic Editor: Jianying Zhang

Copyright © 2013 Yanchun Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. Firestein, “The immunopathogenesis of rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 3, no. 3, pp. 398–406, 1991. View at Google Scholar · View at Scopus
  3. C. N. Serhan and J. Savill, “Resolution of inflammation: the beginning programs the end,” Nature Immunology, vol. 6, no. 12, pp. 1191–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Feig and M. E. Peter, “How apoptosis got the immune system in shape,” European Journal of Immunology, vol. 37, no. 1, pp. S61–S70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Pope, “Apoptosis as a therapeutic tool in rheumatoid arthritis,” Nature Reviews Immunology, vol. 2, no. 7, pp. 527–535, 2002. View at Google Scholar · View at Scopus
  6. R. A. Ihrie, E. Reczek, J. S. Horner et al., “Perp is a mediator of p53-dependent apoptosis in diverse cell types,” Current Biology, vol. 13, no. 22, pp. 1985–1990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Nowak, C. Köster, and M. Hammerschmidt, “Perp is required for tissue-specific cell survival during zebrafish development,” Cell Death and Differentiation, vol. 12, no. 1, pp. 52–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. D. Attardi, E. E. Reczek, C. Cosmas et al., “PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family,” Genes and Development, vol. 14, no. 6, pp. 704–718, 2000. View at Google Scholar · View at Scopus
  9. R. A. Ihrie and L. D. Attardi, “Perp-etrating p53-dependent apoptosis,” Cell Cycle, vol. 3, no. 3, pp. 267–269, 2004. View at Google Scholar · View at Scopus
  10. S. W. Lowe, E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks, “p53 is required for radiation-induced apoptosis in mouse thymocytes,” Nature, vol. 362, no. 6423, pp. 847–849, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Maas, S. Chan, J. Parker et al., “Cutting edge: molecular portrait of human autoimmune disease,” Journal of Immunology, vol. 169, no. 1, pp. 5–9, 2002. View at Google Scholar · View at Scopus
  12. Z. Yao, S. L. Painter, W. C. Fanslow et al., “Human IL-17: a novel cytokine derived from T cells,” Journal of Immunology, vol. 155, no. 12, pp. 5483–5486, 1995. View at Google Scholar · View at Scopus
  13. F. Fossiez, O. Djossou, P. Chomarat et al., “T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines,” Journal of Experimental Medicine, vol. 183, no. 6, pp. 2593–2603, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Chabaud, J. M. Durand, N. Buchs et al., “Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium,” Arthritis and Rheumatism, vol. 42, no. 5, pp. 963–970, 1999. View at Google Scholar
  15. S. Kotake, N. Udagawa, N. Takahashi et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” Journal of Clinical Investigation, vol. 103, no. 9, pp. 1345–1352, 1999. View at Google Scholar · View at Scopus
  16. M. Kohno, A. Tsutsumi, H. Matsui et al., “Interleukin-17 gene expression in patients with rheumatoid arthritis,” Modern Rheumatology, vol. 18, no. 1, pp. 15–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Genovese, F. Van Den Bosch, S. A. Roberson et al., “LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study,” Arthritis and Rheumatism, vol. 62, no. 4, pp. 929–939, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Hueber, D. D. Patel, T. Dryja et al., “Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis,” Science Translational Medicine, vol. 2, no. 52, Article ID 52ra72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M.-L. Toh, G. Gonzales, M. I. Koenders et al., “Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression,” PLoS ONE, vol. 5, no. 10, article e13416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B.-X. Tang, X. You, L.-D. Zhao et al., “p53 in fibroblast-like synoviocytes can regulate T helper cell functions in patients with active rheumatoid arthritis,” Chinese Medical Journal, vol. 124, no. 3, pp. 364–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  22. P. M. Welsing, A. M. van Gestel, H. L. Swinkels, L. A. Kiemeney, and P. L. van Riel, “The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 44, no. 9, pp. 2009–2017, 2001. View at Google Scholar
  23. D. Aletaha, M. M. Ward, K. P. Machold, V. P. K. Nell, T. Stamm, and J. S. Smolen, “Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states,” Arthritis and Rheumatism, vol. 52, no. 9, pp. 2625–2636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Shi, S. Sandoghchian Shotorbani, Z. Su et al., “Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis,” Clinical and Developmental Immunology, vol. 2012, Article ID 295081, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M.-L. Gougeon and M. Piacentini, “New insights on the role of apoptosis and autophagy in HIV pathogenesis,” Apoptosis, vol. 14, no. 4, pp. 501–508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Cacciapaglia, C. Spadaccio, M. Chello et al., “Apoptopic molecular mechanisms implicated in autoimmune diseases,” European Review for Medical and Pharmacological Sciences, vol. 13, no. 1, pp. 23–40, 2009. View at Google Scholar · View at Scopus
  27. Q. Yao, J. C. Glorioso, C. H. Evans et al., “Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining,” Journal of Gene Medicine, vol. 2, no. 3, pp. 210–219, 2000. View at Google Scholar · View at Scopus
  28. D. Moodley, G. M. Mody, and A. A. Chuturgoon, “Initiation but no execution—modulation of peripheral blood lymphocyte apoptosis in rheumatoid arthritis—a potential role for heat shock protein 70,” Journal of Inflammation, vol. 8, article 30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Yamanishi, D. L. Boyle, S. Rosengren, D. R. Green, N. J. Zvaifler, and G. S. Firestein, “Regional analysis of p53 mutations in rheumatoid arthritis synovium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 15, pp. 10025–10030, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Maas, M. Westfall, J. Pietenpol, N. J. Olsen, and T. Aune, “Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1047–1057, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Eshed, E. Feist, C. E. Althoff et al., “Tenosynovitis of the flexor tendons of the hand detected by MRI: an early indicator of rheumatoid arthritis,” Rheumatology, vol. 48, no. 8, pp. 887–891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D.-A. Kim and T.-Y. Kim, “Is serum anti-cyclic citrullinated peptide level useful in the diagnosis of rheumatoid arthritis?” Clinica Chimica Acta, vol. 413, no. 7-8, pp. 831–832, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Rouvier, M.-F. Luciani, M.-G. Mattei, F. Denizot, and P. Golstein, “CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene,” Journal of Immunology, vol. 150, no. 12, pp. 5445–5456, 1993. View at Google Scholar · View at Scopus
  34. B. W. Kirkham, M. N. Lassere, J. P. Edmonds et al., “Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (The DAMAGE Study Cohort),” Arthritis and Rheumatism, vol. 54, no. 4, pp. 1122–1131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Chabaud, E. Lubberts, L. Joosten, W. Van Den Berg, and P. Miossec, “IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis,” Arthritis Research, vol. 3, no. 3, pp. 168–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-S. Kong, S.-A. Yoo, H.-S. Kim et al., “Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 159–170, 2010. View at Publisher · View at Google Scholar · View at Scopus